This topic contains a solution. Click here to go to the answer

Author Question: Use of which of the following drugs is contraindicated for a patient receiving aldesleukin ... (Read 96 times)

sjones

  • Hero Member
  • *****
  • Posts: 520
Use of which of the following drugs is contraindicated for a patient receiving aldesleukin (inter-leukin-2)?
 
  a. Calcium channel blocker
  b. Bronchodilator
  c. Nonopioid analgesic
  d. Corticosteroid

Question 2

Which of the following adverse effects of filgastrim (Neupogen) should the patient be directed to treat with acetaminophen?
 
  a. Bone pain
  b. Heartburn
  c. Abdominal pain
  d. Headache



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chelseyj.hasty

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

ANS: D
Corticosteroids are contraindicated for use during therapy with interleukin-2 because they reduce the antitumor effectiveness of the biologic response modifier.

Answer to Question 2

ANS: A
Bone pain is the most common adverse effect of filgastrim and is due to the extensive bone mar-row regeneration. It can be easily treated with acetaminophen.





 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library